2016 American Transplant Congress
Cost-Effectiveness of Machine Perfusion Use After Long Cold Ischemic Time in a Kidney Transplantation Program.
Renal Transplantation Unit, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
In Brazil the incidence of DGF is very high (60-70%) mainly due to an inadequate care of the donors and long cold ischemia time. This…2016 American Transplant Congress
Long-Term vs Short-Term Valganciclovir Prophylaxis Use for Cytomegalovirus and Epstein-Barr Virus Infections in Pediatric Living Related Liver Transplantation.
[Purpose] Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections are the most important viral infections in pediatric patients with transplant. Valganciclovir (VGCV) has been used as…2016 American Transplant Congress
Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients.
Houston Methodist Hospital, Houston, TX.
Recent literature indicates an elevated rate of de novo DSA (dnDSA) following BK viremia (BKV) in renal transplant recipients (RTR). We sought to review our…2016 American Transplant Congress
Graft Loss Due to Recurrence of Focal Segmental Glomerulosclerosis in Second Renal Transplant.
Transplant, Upstate Medical University, Syracuse, NY.
Introduction : Focal segmental glomerular sclerosis (FSGS) glomerulonephritis can recur in renal transplants, and can potentially lead to graft loss. The rate of graft loss…2016 American Transplant Congress
Give One and Done? Evaluating a Change in Surgical Prophylaxis in Kidney Transplant Recipients.
Pharmacy, University of Utah Hospital and Clinics, Salt Lake City, UT.
Surgical-site infections (SSIs) occur in up to 11% of kidney transplant (txp) patients (pts). There is no consensus on the optimal peri-op prophylaxis regimen for…2016 American Transplant Congress
Mycophenolate Mofetil Dose Reduction Are Associated with the Risk of Acute Rejection and Graft Failure After Renal Transplantation.
Background: Mycophenolate mofetil (MMF) is a highly effective immunosuppressive agent in transplant therapy. Although MMF is generally well tolerated, optimal therapy may be limited by…2016 American Transplant Congress
Outcomes of Ribavirin Free Treatment of Recurrent Genotype 1 , Hepatitis C Infection Post Liver Transplant.
Background. With the development of direct-acting antivirals, the treatment of Hepatitis C Virus (HCV) has become a rapidly changing area of medical practice. Data on…2016 American Transplant Congress
Potential Biomarkers and Treatment for BK Virus Associated Nephropathy.
Background: BK polyomavirus assoiciated nephropathy (BKVAN) is one of the major complications in renal transplants, and is associated with significant fibrosis It is important to…2016 American Transplant Congress
Donor-Specific Antibody Is a Major Independent Predictor of Accelerated Heart Allograft Vasculopathy (CAV).
Introduction The role of circulating DSA in addition to traditional cardiovascular risk factors, in the development of accelerated CAV have not been demonstrated. We investigated…2016 American Transplant Congress
Intestinal Retransplantation in Children: Single Center Experience.
Aim: To analyze the patient and graft characteristics and improvement in patient outcomes for intestinal retransplantation (Re-ITx) in the era of induction immunosuppression with the…
- « Previous Page
- 1
- …
- 63
- 64
- 65
- 66
- 67
- …
- 180
- Next Page »